Status:
COMPLETED
Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU Patients
Lead Sponsor:
King Edward Memorial Hospital
Conditions:
Nosocomial Pneumonia
Healthcare-Associated Pneumonia
Eligibility:
All Genders
13+ years
Phase:
PHASE4
Brief Summary
Oropharyngeal bacteria play an important role in the pathogenesis of nosocomial pneumonia in critically ill patients. Oral cleansing with chlorhexidine has been shown to decrease incidence of pneumoni...
Detailed Description
Nosocomial pneumonia is common in intensive care units (ICU) patients and is associated with increase in mortality rates by 24% to 76% in various studies. Interventions that effectively prevent nosoco...
Eligibility Criteria
Inclusion
- All patients admitted to the medical intensive care unit and are expected to stay in ICU for \> 48 hours
Exclusion
- Pregnant women
- Patients with nosocomial pneumonia at time of ICU admission
- Patients with community-acquired pneumonia at time of ICU admission
- Patients in whom oropharyngeal cleansing is contra-indicated
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
512 Patients enrolled
Trial Details
Trial ID
NCT00610324
Start Date
May 1 2004
End Date
December 1 2007
Last Update
February 7 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical-Neuro Intensive Care Unit, K E M Hospital, Parel
Mumbai, Maharashtra, India, 400012